Both in Biotechnology
Cullinan Therapeutics vs Monte Rosa Therapeutics
Over the past year CGEM returned +155.1% and GLUE returned +60.6%; their daily moves had a correlation of 0.38.
CGEM +155.1% GLUE +60.6%Growth of $1, one year, split-adjusted
| Metric | CGEM | GLUE |
|---|---|---|
| Price | $15.23 | $11.74 |
| Market cap | $980.1M | $1.00B |
| Today | +1.87% | +0.26% |
| 1 month | −29.8% | −12.3% |
| 6 months | +13.5% | −24.4% |
| Year to date | +47.1% | −25.1% |
| 1 year | +155.5% | +56.7% |
| Revenue growth (YoY) | — | −61.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −483.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 34.9× |
| Net cash | $334.5M | $621.1M |
| Dividend yield | — | — |
| Volatility (60d) | 72.3% | 81.8% |
| Short % of float | 18.0% | 39.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).